IP Library Granted Patent US 8,956,867
Granted Patent B2
US 8,956,867 · App. 12/615,044 · Granted Feb 17, 2015

Method for culturing stem cells

Inventors: Timothy J. Kamp (Madison, WI); Jianhua Zhang (Madison, WI); Jeffrey C. Mohr (Glenview, IL); Juan J. Depablo (Madison, WI); Sean P. Palecek (Verona, WI)
Assignee: Wisconsin Alumni Research Foundation
C07K16/18C12N2533/90C12N5/0603
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,956,867
App. No.
12/615,044
Granted
Feb 17, 2015
Kind
B2
Abstract

A three-dimensional microwell system that supports long term pluripotent cell culture and formation of homogeneous embryoid bodies (EBs) is described. Microwell-cultured pluripotent cells remain viable and undifferentiated for several weeks in culture and maintain undifferentiated replication when passaged to Matrigel®-coated, tissue culture-treated polystyrene dishes. Microwell-cultured pluripotent cells maintain pluripotency, differentiating to each of the three embryonic germ layers. Pluripotent cell aggregates released from microwells can be passaged for undifferentiated replication or differentiated to monodisperse EBs. The ability to constrain pluripotent cell growth in three dimensions advantageously provides for more efficient, reproducible culture of undifferentiated cells, high-throughput screening, and the ability to direct pluripotent cell differentiation by generating monodisperse EBs of a desired size and shape. Cardiomyocyte-rich EBs are obtained from pluripotent cells cultured in microwells of defined size and shape.

Claims (9)

1. A method for culturing human pluripotent stem cells to obtain a contracting embryoid body in which at least 50% of cells of the contracting embryoid body express MF20 or MLC2a, the method comprising the steps of:

harvesting aggregates or colonies of substantially undifferentiated human pluripotent stem cells from a microwell that constrains the growth of the human pluripotent stem cells in three dimensions and having a lateral dimension of about 100 microns;

differentiating the harvested aggregates or colonies of pluripotent stem cells under unconstrained culture conditions for a period sufficient to form a population of embryoid bodies comprising a plurality of contracting embryoid bodies, wherein at least 50% of the cells of each contracting embryoid body of the plurality express MF20 or MLC2a.

2. The method of claim 1 , wherein the population of embryoid bodies have a substantially uniform size and shape.

3. The method of claim 1 , wherein each embryoid body comprises a substantially uniform number of cells.

4. The method of claim 1 , wherein the microwell is rectangular.

5. The method of claim 1 , wherein the microwell has a depth between about 10 microns and about 1000 microns.

6. The method of claim 1 , wherein the harvesting step comprises shearing the pluripotent stem cells from the microwell.

7. The method of claim 1 , wherein the dimension-constrained microwell has cell-attracting and cell-repulsing portions.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 6, 2015
From: WISCONSIN ALUMNI RESEARCH FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 034731/0180 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2010
From: KAMP, TIMOTHY; DEPABLO, JUAN; ZHANG, JIANHUA; MOHR, JEFFREY; PALECEK, SEAN
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 024618/0486 →
Continuity (2)
Provisional Application 61112368 · Nov 7, 2008
Related Publication 20100197013A1 · Aug 5, 2010